Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Phase 1 – All groups:
- Both parents have given free, informed, and signed consent
- The participant is enrolled in the social security system
Phase 1 – Adults without autism (ASD):
- Adults between 18 and 50 years old who do not have autism
Phase 1 – Children without autism (ASD):
- Children between 2 and 12 years old who do not have autism
Phase 1 – Children with autism (ASD):
- Children between 2 and 12 years old who have a confirmed autism diagnosis according to recognised international diagnostic standards (DSM-V, ICD-10, or ICD-11)
Phase 2 – Children without a neurodevelopmental disorder (TND):
- Children between 0 and 12 years old who do not have a neurodevelopmental disorder
Phase 2 – Children with a neurodevelopmental disorder (TND), or whose diagnosis is in progress:
- Children between 0 and 12 years old who meet the diagnostic criteria for a neurodevelopmental disorder, or who have been referred and are currently being assessed for one
Who may not be able to join:
Phase 1 – All groups:
- People with a known, uncorrected vision problem
- People with a known personal neurological condition
Phase 1 – Adults without ASD:
- People who are under legal guardianship or trusteeship
- People who have a diagnosis of autism
Phase 1 – Children without ASD:
- Children who have a diagnosis of autism
Phase 1 – Children with ASD:
- Children who have a specific ICD-10 diagnosis of Rett syndrome or Heller syndrome (confirm with trial site)
Phase 2 – Children without a neurodevelopmental disorder:
- Children who have a confirmed or ongoing autism diagnosis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nadia Aguillon-Hernandez, MCU, UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.
Phone: 0247478840
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Oculometric measurements 1: Tracking time; Oculometric measurements 2: Fixation time on the screen; Oculometric measurements 3: Fixation time on the eye area during entire stimuli duration; Oculometric measurements 4: Fixation time on the mouth area of face stimuli; Pupillometric measurements; Discriminative power
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.